BIOCRYST PHARMACEUTICALS INC Underwriting Agreements
8 Contracts & Agreements
- Underwriting Agreement, dated May 27, 2020, by and among BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the... (Filed With SEC on June 1, 2020)
- Underwriting Agreement, dated November 13, 2019, by and between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, as representative of the underwriters named in... (Filed With SEC on November 18, 2019)
- Underwriting Agreement, dated August 1, 2018, by and among BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC and Jefferies LLC, as representatives of the underwriters... (Filed With SEC on August 6, 2018)
- Underwriting Agreement, dated September 12, 2017, by and among BioCryst Pharmaceuticals, Inc., J. P. Morgan Securities LLC and Barclays Capital Inc., as representatives of the... (Filed With SEC on September 15, 2017)
- BIOCRYST PHARMACEUTICALS, INC. 5,294,118 Shares of Common Stock (par value $0.01 per share) Underwriting Agreement (Filed With SEC on March 15, 2017)
- BIOCRYST PHARMACEUTICALS, INC. 10,000,000 Shares of Common Stock (par value $0.01 per share) Underwriting Agreement (Filed With SEC on June 3, 2014)
- BIOCRYST PHARMACEUTICALS, INC. 4,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on August 5, 2013)
- 5,000,000 Shares BIOCRYST PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on November 24, 2009)
